MNM integrates cutting-edge genomics with the latest technological breakthroughs in AI to fight cancer. Our goal is to crack the code of cancer biology.
Our proprietary platform applies AI to a tumor's dark genome to personalize therapy for every cancer patient.
To fulfill our mission “precision therapy for every cancer patient” we have developed a set of specialized assets.
Explore our evidence-based knowledge in genomics and AI.
MNM is a biotech start-up created by an interdisciplinary team of experts -geneticists, molecular biologists, bioinformaticians and AI specialists.
MNM received a Certificate of Conformity with the international ISO 9001: 2015 standard, which means that our organisation provides the highest level of quality, performance and practical handling.